These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21742587)

  • 1. Tigecycline treatment for urinary tract infections: case report and literature review.
    Drekonja DM; Johnson JR
    J Chemother; 2011 Jun; 23(3):168-70. PubMed ID: 21742587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations.
    Cunha BA
    J Chemother; 2011 Jun; 23(3):171-4. PubMed ID: 21742588
    [No Abstract]   [Full Text] [Related]  

  • 3. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.
    Nix DE; Matthias KR
    J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673
    [No Abstract]   [Full Text] [Related]  

  • 4. Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2875-6. PubMed ID: 24879666
    [No Abstract]   [Full Text] [Related]  

  • 5. Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2606-10. PubMed ID: 24879669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
    de Maio Carrillho CM; Gaudereto JJ; Martins RC; de Castro Lima VA; de Oliveira LM; Urbano MR; Perozin JS; Levin AS; Costa SF
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):253-257. PubMed ID: 27939820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
    de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
    Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lower urinary tract infections in men. Urethritis, cystitis and prostatitis].
    Zanella MC; Schoofs F; Huttner B; Huttner A
    Rev Med Suisse; 2017 Apr; 13(558):808-814. PubMed ID: 28727330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection.
    Cunha BA; McDermott B; Nausheen S
    J Chemother; 2007 Dec; 19(6):753-4. PubMed ID: 18230562
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria.
    Guibert J; Destrée D; Konopka C; Acar J
    Eur J Clin Microbiol; 1986 Apr; 5(2):247-8. PubMed ID: 2941292
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
    Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
    Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Etest to determine tigecycline MICs for Enterobacter species.
    Cohen Stuart J; Mouton JW; Diederen BM; Al Naiemi N; Thijsen S; Vlaminckx BJ; Fluit AC; Leverstein-van Hall MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2746-7. PubMed ID: 20350941
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
    Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
    Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola.
    Pan Z; Liu R; Zhang P; Zhou H; Fu Y; Zhou J
    Microb Drug Resist; 2017 Jan; 23(1):127-131. PubMed ID: 27754764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rational antimicrobial therapy of chronic bacterial prostatitis].
    Popov SV
    Antibiot Khimioter; 2013; 58(5-6):32-7. PubMed ID: 24757823
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli.
    Tsai HY; Liao CH; Cheng A; Liu CY; Huang YT; Sheng WH; Hsueh PR
    J Infect; 2012 Dec; 65(6):584-6. PubMed ID: 23000236
    [No Abstract]   [Full Text] [Related]  

  • 19. Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario.
    Shakti L; Veeraraghavan B
    Indian J Med Microbiol; 2015; 33(4):477-81. PubMed ID: 26470951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteriological analysis of more than 600 febrile urinary infections managed in a community health network].
    Bruyère F; Vidoni M; Péan Y; Ruimy JA; Elfassi R
    Prog Urol; 2013 Sep; 23(10):890-8. PubMed ID: 24034802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.